Original Research

Intravenous Administration of Ropivacaine Reduces Minimal Alveolar Concentration of Sevoflurane in Rats

Er-Ya Chen , Hai Chen , Cyrus Rastegar , Chan Chen , Jin Liu
Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China, The Thomas C. Jenkins Department of Biophysics, Johns Hopkins University, Baltimore, MD, USA
J Anesth Perioper Med 2018; 5(6): 275- 280 . Published on Nov 28, 2018 . doi:10.24015/JAPM.2018.0115
Author & Article info


Background: Whether the intravenous infusion of ropivacaine at a constant rate can affect the minimum alveolar concentration (MAC) of sevoflurane in rats and different concentration can produce different effects.
Methods: We used the Dixon “up-and-down” method to determine the MAC of sevoflurane in three groups (20 subjects per group). After a 30-minute equilibration, the medications (saline, 0.5% ropivacaine or 1.0% ropivacaine) were continuously infused at a rate of 0.5 mL/h/kg for 30 minutes, and the response to the supramaximal noxious stimulus was recorded (movement versus no movement).
Results: The MAC was 2.34 ± 0.26% (95% confidence interval [CI], 2.22-2.46) in the saline group, 1.22 ± 0.31% (95%CI, 1.07-1.37) in the 0.5% ropivacaine group, and 1.06 ± 0.42% (95%CI, 0.86-1.26) in the 1.0% ropivacaine group. The MAC of the 0.5% ropivacaine (mean difference of 1.12% sevoflurane [95% adjusted CI, 0.86-1.38]; P < 0.01) and 1.0% ropivacaine groups (mean difference of 1.28% sevoflurane [95% adjusted CI, 1.02-1.54]; P < 0.01) were significantly lower than that of the saline group.   
Conclusion: Intravenous administration of 0.5% and 1.0% ropivacaine both decreased the MAC of sevoflurane in rats, and 1.0% ropivacaine showed more decline. (Funded by the Distinguished Professorships Awards from the China Medical Board.) 
Citation: Er-Ya Chen, Hai Chen, Cyrus Rastegar, Chan Chen, Jin Liu. Intravenous Administration of Ropivacaine Reduces Minimal Alveolar Concentration of Sevoflurane in Rats. J Anesth Perioper Med 2018;5:275-280. doi: 10.24015/JAPM.2018.0115
This is an open-access article, published by Evidence Based Communications (EBC). This work is licensed under the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium or format for any lawful purpose. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.


Copyright © 2014-2018 | Evidence Based Communications (EBC)   All Rights Reserved.
Privacy Policy | Terms of Use | NIH Public Access Policy
ISSN: 2306-773X (Print) and 2520-3002 (Online)Submit a Manuscript | EBC and EBC Journals

The content on this site is intended for health professionals.